Now is the time to ask questions and begin taking steps to ensure that GLP-1s, like all other treatments, are being utilized responsibly and at prices that enable financially sustainable treatment plans for the ongoing benefit of all
There are no long-term trials assessing its efficacy, safety, or consistency over time
Purchasing from a reputable vendor ensures safety, accurate dosing, and traceabilityfactors essential for both research and personal experimentation
Many underlying issues remain untouched, including: Hormonal imbalances Insulin resistance Chronic inflammation Poor gut health Stress-related cortisol elevation Nutrient deficiencies When the medication is stopped, the body often rebounds because the root causes were never resolved
28 , 849857 (1985) Sciabola, S
When the two groups were analyzed side by side, a clear pattern emerged: those taking GLP-1 medications had up to a 29% higher risk of developing a chronic cough during the first five years of treatment